JBT Marel (JBTM) AI Stock Analysis

• Market Cap: $8.52B
• Dividend Yield: 0.26%
• Average Volume (3M): 483.08K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.68
• Revenue Growth: 91.98%
• EPS Growth: -141.14%
• Country: US
• Employees: 11,700
• Sector: Industrials
• Sector Strength: 72
• Industry: Industrial - Machinery
• EPS (TTM): 1.98
• Shares Outstanding: 51,971,370
• 10 Day Avg. Volume: 609,523
• 30 Day Avg. Volume: 483,077
• PEG Ratio: 1.13
• Price to Book (P/B): 1.76
• Price to Sales (P/S): 2.06
• P/FCF Ratio: 32.91
• Enterprise Value/Market Cap: 1.16
• Enterprise Value/Revenue: 2.59
• Enterprise Value/Gross Profit: 7.38
• Enterprise Value/Ebitda: 32.61
• 1Y Price Target: $191.00
• Price Target Upside: 21.82% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 3
• EPS Forecast (FY): 7.83
• Revenue Forecast (FY): $3.96B

• Rating: 68 Neutral
• Price Target: $178.00 ▲(13.53% Upside)
• Action: Reiterated Date: 02/24/26
• Date: Action: Reiterated 02/24/26

The score is driven primarily by improving financial stability (material deleveraging) and strong top-line momentum, supported by constructive technical uptrend signals. Offsetting factors are weaker reported profitability (net loss/EBITDA margin compression) and an unattractive earnings-based valuation (negative P/E), while the latest earnings call guidance and synergy execution provide a meaningful positive forward-looking boost despite tariff-related risk.

Positive Factors

Material Deleveraging

A sharply de-risked capital structure materially lowers financial risk and increases flexibility for capex, M&A, and synergy funding. Sustained low leverage supports investment-grade-like resilience, reduces interest costs, and provides a multi-month runway to execute margin recovery and growth plans.

Robust Orders and Backlog

Strong order intake and backlog conversion indicate durable end-market demand, especially in poultry and protein segments. High backlog supports revenue visibility over the next several quarters, enabling steady production planning, capacity utilization and predictable cash conversion as orders convert to revenue.

Synergy Delivery & Margin Guidance

Documented synergy capture plus management guidance for higher adjusted EBITDA margins reflect lasting operational improvements. Realized and targeted run-rate savings support sustainable margin expansion, improving long-term cash flow conversion and funding for strategic initiatives beyond one reporting period.

Negative Factors

Weakened Reported Profitability

A swing to a net loss and compressed EBITDA margin signal structural earnings-quality issues like cost absorption failures or one-off charges. If below-the-line losses persist, they can erode retained earnings, limit reinvestment capacity, and impair sustainable free cash flow even with strong top-line trends.

Tariff-Related Cost Pressure

Ongoing tariff exposure is a structural margin headwind that reduces pricing flexibility and raises input costs. Policy uncertainty makes cost forecasting and pricing cadence harder, potentially forcing sustained margin dilution or recurring pass-through cycles that compress competitiveness over many quarters.

Operational & Supply-Chain Transition Risk

Execution challenges in Prepared Foods and a multi-year regionalization of supply chains create prolonged cost and efficiency risk. These structural operational shifts can depress near-term margins, require continued investment, and introduce execution risk that may blunt expected synergy and margin gains.

JBT Marel Business Overview & Revenue Model

Company Description

JBT Marel Corporation provides technology solutions to food and beverage industry in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers value-added processing that includes chilling, mixing/grinding, injecting, blending, marinating, tumbling, flattening, forming, portioning, coating, cooking, frying, freezing, extracting, pasteurizing, sterilizing, concentrating, high pressure processing, weighing, inspecting, filling, closing, sealing, end of line material handling, and packaging solutions to the food, beverage, and health market. In addition, it offers automated guided vehicle systems for material movement in the manufacturing, warehouse, and medical facilities. It serves baby food, bakery and confectionery, citrus processing, fruits and nuts, juices, non-food, pet food, pharmaceutical, plant- based beverages and protein, poultry, meat, and seafood, ready meals, oils, soups, sauces, seasoning and dressings, automotive, building material, tissue, paper, and packaging, hospitals, pharma and life sciences, fast moving consumer goods, manufacturing, warehousing, and other industries. The company markets and sells its products and solutions through direct sales force, independent distributors, sales representatives, and technical service teams. The company was formerly known as John Bean Technologies Corporation and changed its name to JBT Marel Corporation in January 2025. JBT Marel Corporation was incorporated in 1994 and is headquartered in Chicago, Illinois.

How the Company Makes Money

JBT Marel generates revenue through multiple streams, primarily from the sale of equipment and systems used in food processing and food service. Key revenue sources include the sale of machinery, parts, and maintenance services, as well as software solutions for operational management. Additionally, JBTM earns income from long-term service agreements and support contracts that provide ongoing maintenance and upgrades to their equipment. Strategic partnerships with major food processors and continuous innovation in their product offerings further contribute to their earnings, enabling them to capture a significant share of the growing demand for efficient and safe food processing technologies.

JBT Marel Financial Statement Overview

Summary

Revenue growth was strong in 2025 (+16.6%) and leverage improved sharply (debt-to-equity ~0.09), supporting financial resilience. Offsetting this, profitability deteriorated to a net loss with a much lower EBITDA margin (~5%) and free-cash-flow consistency has been uneven despite solid 2025 FCF (~$238M).

Income Statement

Revenue growth accelerated sharply in 2025 (annual report: +16.6%) on a much larger sales base, and gross margin has been relatively steady in the mid-30% range. However, profitability deteriorated meaningfully in 2025 with a swing to a net loss (net margin -1.3%) and a much lower EBITDA margin (~5%) versus 2024 (~11.9%) and 2023 (~16.1%), indicating weaker cost absorption and/or higher below-the-line charges. Overall: strong top-line momentum but weakened earnings quality and margins in the latest year.

Balance Sheet

Leverage improved substantially in 2025, with debt-to-equity falling to ~0.09 from ~0.81 in 2024 and ~1.08 in 2022, suggesting a materially de-risked capital structure. Equity and assets increased significantly in 2025, improving balance sheet capacity. Key watch-out: despite the stronger balance sheet, the latest year produced a net loss, which can weigh on future capital generation if it persists.

Cash Flow

Cash generation was solid in 2025 with operating cash flow of ~$342M and free cash flow of ~$238M, following healthy 2024 free cash flow (~$196M). Free cash flow growth turned negative in 2025 (-12.9%), and cash conversion has been volatile historically (notably negative free cash flow in 2023). Also, in 2025 the company produced positive free cash flow despite a net loss, which is supportive in the near term but highlights a disconnect between reported earnings and cash results that bears monitoring.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	3.80B	1.72B	1.66B	1.59B	1.40B
Gross Profit	1.33B	626.50M	585.70M	529.40M	482.10M
EBITDA	301.60M	204.20M	268.70M	212.50M	202.80M
Net Income	-50.50M	85.40M	582.60M	137.40M	119.10M
Balance Sheet
Total Assets	8.20B	3.41B	2.71B	2.64B	2.14B
Cash, Cash Equivalents and Short-Term Investments	186.50M	1.23B	483.30M	71.70M	78.80M
Total Debt	1.88B	1.25B	646.40M	977.90M	674.40M
Total Liabilities	3.73B	1.87B	1.22B	1.74B	1.39B
Stockholders Equity	4.46B	1.54B	1.49B	905.40M	750.20M
Cash Flow
Free Cash Flow	238.10M	195.70M	-15.50M	57.70M	172.10M
Operating Cash Flow	341.70M	233.60M	39.60M	142.30M	223.80M
Investing Cash Flow	-1.84B	-41.30M	725.90M	-416.10M	-272.90M
Financing Cash Flow	458.10M	561.80M	-354.10M	270.60M	80.80M

JBT Marel Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 156.79
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JBTM, the sentiment is Neutral. The current price of 156.79 is below the 20-day moving average (MA) of 162.91, below the 50-day MA of 158.19, and above the 200-day MA of 139.02, indicating a neutral trend. The MACD of 1.34 indicates Positive momentum. The RSI at 42.19 is Neutral, neither overbought nor oversold. The STOCH value of 32.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JBTM.

JBT Marel Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SPXC	76 Outperform	$12.11B	45.02	12.76%	―	12.60%	24.02%
FLS	73 Outperform	$11.52B	34.24	16.49%	1.17%	3.19%	69.89%
GTES	69 Neutral	$7.12B	28.45	7.93%	―	-0.75%	9.22%
JBTM	68 Neutral	$8.52B	-155.36	-3.65%	0.26%	91.98%	-141.14%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
MIR	63 Neutral	$5.27B	196.08	1.71%	―	7.81%	―
MIDD	60 Neutral	$8.11B	-35.84	-6.20%	―	0.27%	-159.24%

JBT Marel Corporate Events

JBT Marel Implements New Segment Reporting After Integration

On February 18, 2026, JBT Marel said that a previously announced realignment of its reportable segments took effect for the fourth quarter of 2025, following its January 2, 2025 acquisition of Marel hf., consolidating legacy JBT and Marel operations. The company now reports through two segments, Protein Solutions and Prepared Food and Beverage Solutions, with historical results recast for 2023–2025 for comparability, and it emphasized that the change does not affect previously reported consolidated revenue, earnings, earnings per share, or total assets, but better aligns financial reporting with its integrated operating model for management and stakeholders.

For the quarter ended March 31, 2025, Protein Solutions generated $377.7 million in revenue and Prepared Food and Beverage Solutions $476.4 million, producing total segment adjusted EBITDA of $140.6 million but a pre-tax loss of $219.2 million after significant pension, M&A, restructuring and other unallocated costs. In the quarter ended June 30, 2025, segment revenues rose to $421.5 million and $513.3 million, respectively, with combined segment adjusted EBITDA of $179.7 million and income from continuing operations before taxes of $11.6 million, illustrating improved profitability as integration progressed despite ongoing restructuring and transaction-related charges.

The most recent analyst rating on (JBTM) stock is a Buy with a $171.00 price target. To see the full list of analyst forecasts on JBT Marel stock, see the JBTM Stock Forecast page.